Tags (4) : innovative therapies
Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies
03/31/2026 | Companies
annual report 2025,
biopharma,
breakthrough medicines,
corporate sustainability,
CSRD,
ESRS,
EU Taxonomy,
global biopharma,
healthcare access,
innovative therapies,
Nasdaq Stockholm,
patient care,
pharmaceutical revenue,
pipeline development,
rare disease treatments,
rare diseases,
scientific expertise,
Sobi,
sustainability report 2025,
Swedish Orphan Biovitrum,
TCFD
Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China
03/23/2026 | Companies
BBM-H803,
BBM-H901,
Belief BioMed,
biotech industry,
biotechnology partnership,
China healthcare,
clinical development,
commercialization rights,
drug development,
gene therapy,
Grand Life Sciences,
healthcare innovation,
hematology,
hemophilia A,
hemophilia treatment,
innovative therapies,
medical research,
pharmaceutical collaboration,
rare diseases
Viatris Global Health Initiatives: Advancing NCD Care, Mental Health, and Digital Therapeutics
10/17/2025 | Companies
accessible medicine,
anxiety,
Apixaban,
art therapy,
blood pressure management,
BPV advocacy,
cardiovascular disease,
clinical trials,
Cystadrops,
depression,
dermatology,
diabetes,
digital health,
digital therapeutics,
disease management,
Dymista,
Elidel,
global collaboration,
global health,
global initiatives,
government partnerships,
HCP training,
health apps,
healthcare access,
healthcare technology,
hypertension,
hypertension awareness,
immersive VR therapy,
innovative therapies,
medication adherence,
mental health,
mental health awareness,
multiple sclerosis,
NCDs,
noncommunicable diseases,
ophthalmology,
patient education,
patient outcomes,
patient support,
pharmaceutical launches,
pharmacovigilance,
podcasts,
PrGlatiramer Acetate,
public health campaigns,
Relpax,
research,
respiratory diseases,
Rizmoic,
RRMS,
RYZUMVI,
sotagliflozin,
stigma reduction,
stroke,
Sugammadex,
telemedicine,
Viatris,
Zeforus
Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
American Society of Clinical Oncology,
ASCO,
cancer research,
cancer treatment,
CAR T-cell therapy,
clinical trials,
collaborative research,
EHA,
European Hematology Association,
GileadNews,
hematology,
innovative therapies,
investigational therapy,
Kite Pharma,
metastatic triple-negative breast cancer,
oncology,
Phase 2 results,
recurrent glioblastoma,
refractory multiple myeloma,
relapsed multiple myeloma
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies